Global Pharmaceuticals & Biotech Most Popular Stocks

GT Biopharma

Market Cap: US$2.7m

A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.

Vitruvia Medical

Market Cap: €2.3m

A technology company, operates in the healthcare sector.

Aoxing Pharmaceutical Company

Market Cap: US$2.7m

A specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China.

Biotron

Market Cap: AU$4.0m

A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.

Zenith Healthcare

Market Cap: ₹227.9m

Manufactures and markets pharmaceutical formulations in India.

ProtoKinetix

Market Cap: US$2.5m

A research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).

Azitra

Market Cap: US$2.5m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

Spermosens

Market Cap: SEK 23.5m

Provides diagnostic health care products and services in Sweden.

Windtree Therapeutics

Market Cap: US$2.5m

A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.

City View Green Holdings

Market Cap: CA$3.4m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.

MindBio Therapeutics

Market Cap: CA$3.4m

Operates as a clinical stage drug development company in Australasia.

Universe Pharmaceuticals

Market Cap: US$2.5m

Through its subsidiaries, engages in the manufacturing, marketing, distribution, and sells of traditional Chinese medicine derivative products in China.

BioInfra Life Science

Market Cap: ₩3.4b

A healthcare company, develops cancer gene treatments and technologies that monitor the possibility of metastasis and recurrence in blood for cancer patients in South Korea.

Ridder Titan Genesis

Market Cap: US$2.4m

A medical marijuana company, focuses on the development of whole plant extractions for the cancer and palliative treatments.

Power Fulx

Market Cap: ₩3.3b

Manufactures and sells muscle pain relief, body slimming, and sun protection creams in South Korea.

Prostatype Genomics

Market Cap: SEK 21.8m

Prostatype Genomics AB manufactures, markets, and sells prognostic gene tests.

Panacea Life Sciences Holdings

Market Cap: US$2.3m

Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.

Yubo International Biotech

Market Cap: US$2.3m

Through its subsidiaries, focuses on the research, development, and application of endometrial stem cells.

Sunrest Lifescience

Market Cap: ₹202.5m

Manufactures, sells, and markets healthcare products, medicines, and cosmetic products in India.

Anatara Lifesciences

Market Cap: AU$3.4m

Engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia.

Aptahem

Market Cap: SEK 20.9m

A biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.

Hamps Bio

Market Cap: ₹194.5m

Provides pharmaceutical, freeze dried, and frozen products in India and internationally.

Kaya Holdings

Market Cap: US$2.2m

A vertically integrated legal cannabis enterprise, operates psychedelic treatment clinics and medical cannabis dispensaries in the United States.

CDT Equity

Market Cap: US$2.2m

A clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility.

Silexion Therapeutics

Market Cap: US$2.1m

A biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.

VG Life Sciences

Market Cap: US$2.1m

A biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation.

Vectus Biosystems

Market Cap: AU$3.2m

Engages in the medical research and development activities in Australia.

PlantArc Bio

Market Cap: ₪6.9m

Operates as an Ag-Bio company for the crop protection and yield enhancement.

Coretech 5 Société anonyme

Market Cap: €1.7m

A pharmaceutical development company, engages in the development and marketing of various veterinary solutions for pets.

Scinai Immunotherapeutics

Market Cap: US$2.0m

A biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel.

Salarius Pharmaceuticals

Market Cap: US$2.0m

Operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need.

genedrive

Market Cap: UK£1.5m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

Craftport Cannabis

Market Cap: CA$2.7m

Engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada.

Enveric Biosciences

Market Cap: US$2.0m

A biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.

CannaPharmaRX

Market Cap: US$2.0m

Engages in acquisition, development, and operation of cannabis cultivation facilities in Canada.

Nextgen Biomed

Market Cap: ₪6.6m

Develops topical treatment for psoriasis.